GlassScriptPhysician profile
Andrew R Getzin
NPI 1962458406
$510.02
in general payments reported to CMS, 2019-2025
8 companies · $194 in 2025
The $194 reported for 2025 was more than what a typical Sports Medicine (Family Medicine) provider received nationally (typical 2025 total: $113).
See the full distribution for Sports Medicine (Family Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $151 · 2022: $58.58 · 2023: $49.24 · 2024: $56.64 · 2025: $194.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $300.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $300.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Protega Pharmaceutials INC | $112.01 | 2025 | Roxybond |
| Merck Sharp & Dohme LLC | $109.60 | 2019 | |
| Spr Therapeutics, INC | $82.31 | 2025 | Sprint Pns System |
| Si-Bone, INC. | $58.58 | 2022 | |
| Philips North America LLC | $56.64 | 2024 | (8666) 5500 Series Ultrasound System |
| Hydrocision, INC. | $49.24 | 2023 | Tenjet |
| Teva Pharmaceuticals USA, INC. | $33.76 | 2019 | |
| Fidia Pharma USA INC. | $7.88 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Getzin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.